跳至主要内容
临床试验/EUCTR2012-002633-11-ES
EUCTR2012-002633-11-ES进行中(未招募)1 期

An open label, randomised, adaptive, multicenter, pharmacokinetic/pharmacodynamic, phase Ib, study of oseltamivir (Tamiflu®) in the treatment of influenza in immunocompromised children, between 0-18 years of age, with confirmed influenza infection.

F. Hoffmann-La Roche Ltd.0 个研究点目标入组 21 人开始时间: 2012年10月22日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Male or female immunocompromised patients below 18 years of age with confirmed influenza (flu) infection
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 21
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients with hepatic decompensation, renal impairment or recent treatment with anti-viral medication.

研究者

相似试验

进行中(未招募)
1 期
A study in children and young adults with weak immunity and influenza (flu) infection to understand how the study drug (Tamiflu) improves the recovery from influenza (flu).Treatment of influenza in immunocompromised paedriatric patients.MedDRA version: 14.1Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestations
EUCTR2012-002633-11-ITF. Hoffmann-La Roche Ltd.30
进行中(未招募)
不适用
Bioequivalence study of Azathioprine to measure the pharmacokinetic profiles, safety and tolerability of Test product when compared to the reference product.
CTRI/2014/11/005175Alkem Laboratories Ltd40
进行中(未招募)
不适用
A bio-equivalence study to characterize the rate and extent of absorption of Melphalan after oraladministration and to assess the bioequivalence of the sponsorâ??s test productMelphalan Tablets 2 mg relative to that of the reference product ALKERAN®(melphalan) Tablets 2 mg in adult patients
CTRI/2013/12/004205Alvogen Pine Brook Inc60
已完成
不适用
A multicenter trial to characterize the rate and extent of Methotrexate absorption after oral administration and to assess the bioequivalence of the Methotrexate Tablets, USP 2.5mg
CTRI/2018/10/015921otus Pharmaceutical Co Ltd50
已完成
不适用
Bioequivalence study of Quetiapine Fumarate 300 mg tablets in adult schizophrenia patients, who was already receiving Quetiapine in a stable regime
CTRI/2019/08/020536Prinston Pharmaceutical Inc